"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant epithelial tumor with a glandular organization.
| Descriptor ID |
D000230
|
| MeSH Number(s) |
C04.557.470.200.025
|
| Concept/Terms |
Adenocarcinoma- Adenocarcinoma
- Adenocarcinomas
- Adenoma, Malignant
- Adenomas, Malignant
- Malignant Adenoma
- Malignant Adenomas
Carcinoma, Granular Cell- Carcinoma, Granular Cell
- Carcinomas, Granular Cell
- Granular Cell Carcinoma
- Granular Cell Carcinomas
- Adenocarcinoma, Granular Cell
- Adenocarcinomas, Granular Cell
- Granular Cell Adenocarcinoma
- Granular Cell Adenocarcinomas
Adenocarcinoma, Tubular- Adenocarcinoma, Tubular
- Adenocarcinomas, Tubular
- Tubular Adenocarcinoma
- Tubular Adenocarcinomas
- Carcinoma, Tubular
- Carcinomas, Tubular
- Tubular Carcinoma
- Tubular Carcinomas
Carcinoma, Cribriform- Carcinoma, Cribriform
- Carcinomas, Cribriform
- Cribriform Carcinoma
- Cribriform Carcinomas
Adenocarcinoma, Basal Cell- Adenocarcinoma, Basal Cell
- Adenocarcinomas, Basal Cell
- Basal Cell Adenocarcinoma
- Basal Cell Adenocarcinomas
Adenocarcinoma, Oxyphilic- Adenocarcinoma, Oxyphilic
- Adenocarcinomas, Oxyphilic
- Oxyphilic Adenocarcinoma
- Oxyphilic Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma".
- Adenocarcinoma
- Adenocarcinoma in Situ
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenocarcinoma, Mucinous
- Adenocarcinoma, Papillary
- Adenocarcinoma, Scirrhous
- Adenocarcinoma, Sebaceous
- Adrenocortical Carcinoma
- Carcinoid Tumor
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Skin Appendage
- Cholangiocarcinoma
- Choriocarcinoma
- Cystadenocarcinoma
- Eccrine Porocarcinoma
- Paget Disease, Extramammary
- Pulmonary Adenomatosis, Ovine
This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 5 | 3 | 8 |
| 1996 | 6 | 3 | 9 |
| 1997 | 4 | 2 | 6 |
| 1998 | 2 | 2 | 4 |
| 1999 | 8 | 6 | 14 |
| 2000 | 1 | 4 | 5 |
| 2001 | 5 | 2 | 7 |
| 2002 | 7 | 0 | 7 |
| 2003 | 8 | 4 | 12 |
| 2004 | 8 | 3 | 11 |
| 2005 | 8 | 4 | 12 |
| 2006 | 5 | 3 | 8 |
| 2007 | 9 | 3 | 12 |
| 2008 | 4 | 6 | 10 |
| 2009 | 11 | 4 | 15 |
| 2010 | 11 | 1 | 12 |
| 2011 | 13 | 3 | 16 |
| 2012 | 12 | 3 | 15 |
| 2013 | 11 | 3 | 14 |
| 2014 | 17 | 3 | 20 |
| 2015 | 11 | 2 | 13 |
| 2016 | 12 | 2 | 14 |
| 2017 | 17 | 2 | 19 |
| 2018 | 4 | 0 | 4 |
| 2019 | 6 | 1 | 7 |
| 2020 | 5 | 0 | 5 |
| 2021 | 4 | 0 | 4 |
| 2022 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy. Ann Hematol. 2023 02; 102(2):461-462.
-
Emerging Roles for Family Physicians in Diagnosing and Treating Barrett Esophagus. Am Fam Physician. 2022 Oct; 106(4):368-369.
-
Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2. Molecules. 2022 Jan 19; 27(3).
-
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2022 02; 23(2):259-269.
-
Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia. Gastrointest Endosc. 2022 Apr; 95(4):626-633.
-
A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer. Biomed Pharmacother. 2021 Nov; 143:112226.
-
Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors. Sci Rep. 2021 05 10; 11(1):9920.
-
High-Fat Diet Drives an Aggressive Pancreatic Cancer Phenotype. J Surg Res. 2021 08; 264:163-172.
-
Travel distance and its interaction with patient and hospital factors in pancreas cancer care. Am J Surg. 2021 04; 221(4):819-825.
-
Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous interventions. Gastrointest Endosc. 2021 01; 93(1):154-162.e5.